Press releases
- Savara to Present New Data on Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 2024
- Savara Announces New Employment Inducement Grant
- Savara Reports Fourth Quarter/Year-End 2023 Financial Results and Provides Business Update
- Savara to Present at the Barclays 26th Annual Global Healthcare Conference
Key statistics
As of last trade Savara Inc (YB4P:DUS) traded at 4.54, -10.98% below its 52-week high of 5.10, set on Mar 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.54 |
---|---|
High | 4.54 |
Low | 4.54 |
Bid | 4.52 |
Offer | 4.64 |
Previous close | 4.48 |
Average volume | 0.00 |
---|---|
Shares outstanding | 138.18m |
Free float | 130.40m |
P/E (TTM) | -- |
Market cap | 683.97m USD |
EPS (TTM) | -0.3424 USD |
Data delayed at least 15 minutes, as of May 07 2024 08:30 BST.
More ▼